DaVita Inc. (DVA) by event type
DVA moves most on analyst downgrades — a median of -0.56% at 30 minutes across 10 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the DVA overview →
How DVA reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 1,491 of 2,717 | 17 | -0.01% | 41% | +1.02% |
| Analyst downgrades 2,252 of 2,603 | 10 | -0.56% | 20% | +0.08% |
| Rating reiterations 2,782 of 3,522 | 43 | -0.15% | 44% | +0.09% |
| Price-target raises 1,371 of 1,790 | 16 | -0.11% | 44% | -0.01% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how DVA usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · Price-target raises → · DVA overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Vaxart, Inc. (VXRT) | 341 | -0.81% | 41% |
| Cidara Therapeutics, Inc. (CDTX) | 339 | +0.06% | 52% |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 339 | +0.29% | 51% |
| Cellect Biotechnology Ltd. - American Depositary Shares (APOP) | 337 | -0.42% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.